Cargando…
SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity
Seroprevalence surveys suggest that more than a third and possibly more than half of the global population has been infected with SARS-CoV-2 by early 2022. As large numbers of people continue to be infected, the efficacy and duration of natural immunity in terms of protection against SARS-CoV-2 rein...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Authors. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824301/ https://www.ncbi.nlm.nih.gov/pubmed/35149106 http://dx.doi.org/10.1016/j.envres.2022.112911 |